Gene Transfer
Showing 1 - 25 of 8,301
Long-Term Follow-Up of Recipient of Gene Transfer Research
Recruiting
- Retroviridae Infections
- Cancer
- Blood Tests
- Questionnaires
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 22, 2022
Parkinson Disease Trial in United States (AAV-GAD)
Enrolling by invitation
- Parkinson Disease
- AAV-GAD
-
West Bloomfield, Michigan
- +4 more
Jun 7, 2023
Parkinson Disease Trial in West Bloomfield, Philadelphia, Morgantown (AAV-GAD, Sham Surgery)
Recruiting
- Parkinson Disease
- AAV-GAD
- Sham Surgery
-
West Bloomfield, Michigan
- +2 more
Jan 2, 2023
Spinal Muscular Atrophy 1 Trial in Columbus (AVXS-101)
Completed
- Spinal Muscular Atrophy 1
- AVXS-101
-
Columbus, OhioNationwide Children's Hospital
Aug 30, 2022
Krabbe Disease Trial in Ann Arbor (FBX-101)
Recruiting
- Krabbe Disease
- FBX-101
-
Ann Arbor, MichiganUniversity of Michigan Hospitals - Michigan Medicine
Aug 24, 2022
Subjects Previously Enrolled in Poxviral Vector Gene Transfer
Recruiting
- Prostate Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 19, 2022
Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-9003)
Enrolling by invitation
- Limb Girdle Muscular Dystrophy
- SRP-9003
-
Columbus, OhioNationwide Children's Hospital
May 17, 2023
Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-6004)
Enrolling by invitation
- Limb Girdle Muscular Dystrophy
- SRP-6004
-
Columbus, OhioNationwide Children's Hospital
Jun 7, 2023
Hemophilia B Trial in United Kingdom, United States (Gene Transfer, scAAV2/8-LP1-hFIXco)
Active, not recruiting
- Hemophilia B
- Gene Transfer
- scAAV2/8-LP1-hFIXco
-
Stanford, California
- +7 more
Nov 17, 2022
Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)
Recruiting
- Severe Combined Immunodeficiency Disease, X-linked
- CL20-i4-EF1α-hγc-OPT
- +2 more
-
San Francisco, California
- +2 more
Jan 9, 2023
MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Australia, Spain, United States (ABO-102)
Active, not recruiting
- MPS IIIA
- +3 more
- ABO-102
-
Columbus, Ohio
- +4 more
Nov 8, 2022
Lysosomal Diseases, Gangliosidosis, GM1 Trial run by the NHGRI (biological, drug, diagnostic test, other, procedure, behavioral)
Recruiting
- Lysosomal Diseases
- +2 more
- AAV9-GLB1
- +20 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Suspended
- X-linked Severe Combined Immunodeficiency (XSCID)
- Palifermin
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Duchenne Muscular Dystrophy Trial in Columbus (rAAVrh74.MCK.GALGT2)
Active, not recruiting
- Duchenne Muscular Dystrophy
- rAAVrh74.MCK.GALGT2
-
Columbus, OhioNationwide Children's Hospital
Jul 26, 2022
Multiple System Atrophy Trial in Irvine, Columbus (AAV2-GDNF gene therapy, Sham (Placebo) Surgery)
Recruiting
- Multiple System Atrophy
- AAV2-GDNF gene therapy
- Sham (Placebo) Surgery
-
Irvine, California
- +1 more
Jan 18, 2023
Severe Combined Immunodeficiency, X Linked, Gene Therapy Trial in United Kingdom, United States (autologous CD34+ cell
Recruiting
- Severe Combined Immunodeficiency, X Linked
- Gene Therapy
- autologous CD34+ cell transduced with G2SCID vector
-
Los Angeles, California
- +4 more
Jul 19, 2022
Hereditary Pulmonary Alveolar Proteinosis Trial (Gene-Corrected Macrophages administered by bronchoscopic instillation)
Not yet recruiting
- Hereditary Pulmonary Alveolar Proteinosis
- Gene-Corrected Macrophages administered by bronchoscopic instillation
- (no location specified)
Mar 8, 2023
Mucopolysaccharidosis Type 3 B Trial in Worldwide (rAAV9.CMV.hNAGLU)
Terminated
- Mucopolysaccharidosis Type 3 B
- rAAV9.CMV.hNAGLU
-
Columbus, Ohio
- +3 more
Apr 29, 2022
Sickle Cell Disease Trial in Los Angeles, Boston (single infusion of autologous bone marrow derived CD34+ HSC cells transduced
Active, not recruiting
- Sickle Cell Disease
- single infusion of autologous bone marrow derived CD34+ HSC cells transduced with the lentiviral vector containing a short-hairpin RNA targeting BCL11a
-
Los Angeles, California
- +1 more
Feb 8, 2022
Sickle Cell Disease Trial in Boston (Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA
Recruiting
- Sickle Cell Disease
- Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA targeting BCL11a
-
Los Angeles, California
- +8 more
Jan 10, 2023
CLN3, Batten Disease Trial in Columbus (AT-GTX-502)
Active, not recruiting
- CLN3
- Batten Disease
- AT-GTX-502
-
Columbus, OhioNationwide Children's Hospital
Jul 18, 2022
Hemophilia A Trial in Milwaukee (Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human
Recruiting
- Hemophilia A
- Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022
CLN6 Batten Disease Subjects Following Gene Transfer
Active, not recruiting
- CLN6
- Batten Disease
- AT-GTX-501
-
Columbus, OhioNationwide Children's Hosptial
Dec 17, 2021
Krabbe Disease Trial in Ann Arbor (FBX-101)
Recruiting
- Krabbe Disease
- FBX-101
-
Ann Arbor, MichiganUniversity of Michigan Hospitals - Michigan Medicine
Feb 13, 2023